241 related articles for article (PubMed ID: 9834067)
1. The role of host (endogenous) T cells in chronic graft-versus-host autoimmune disease.
Chen F; Maldonado MA; Madaio M; Eisenberg RA
J Immunol; 1998 Dec; 161(11):5880-5. PubMed ID: 9834067
[TBL] [Abstract][Full Text] [Related]
2. Autoimmunity following neonatal tolerance to alloantigens: role of donor I-A and I-E molecules.
Kramar G; Schurmans S; Berney M; Izui S; del Giudice G; Lambert PH
J Autoimmun; 1995 Apr; 8(2):177-92. PubMed ID: 7612147
[TBL] [Abstract][Full Text] [Related]
3. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of the induction of autoimmune disease by graft-versus-host reaction. Role of CD8+ cells in the development of hepatic and ductal lesions induced by CD4+ cells in MHC class I plus II-different host.
Suzuki K; Narita T; Yui R; Asakura H; Fujiwara M
Lab Invest; 1994 May; 70(5):609-19. PubMed ID: 8196358
[TBL] [Abstract][Full Text] [Related]
5. Conventional B cells, not B1 cells, are the source of autoantibodies in chronic graft-versus-host disease.
Reap EA; Sobel ES; Jennette JC; Cohen PL; Eisenberg RA
J Immunol; 1993 Dec; 151(12):7316-23. PubMed ID: 7505027
[TBL] [Abstract][Full Text] [Related]
6. Depletion of CD8+ cells exacerbates organ-specific autoimmune diseases induced by CD4+ T cells in semiallogeneic hosts with MHC class II disparity.
Saitoh T; Ikarashi Y; Ito S; Watanabe H; Fujiwara M; Asakura H
J Immunol; 1990 Nov; 145(10):3268-75. PubMed ID: 2121823
[TBL] [Abstract][Full Text] [Related]
7. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
Johnson BD; Becker EE; LaBelle JL; Truitt RL
J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
[TBL] [Abstract][Full Text] [Related]
8. Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease.
Leibnitz RR; Lipsky PE; Thiele DL
J Immunol; 1994 Dec; 153(11):4959-68. PubMed ID: 7963559
[TBL] [Abstract][Full Text] [Related]
9. CD3+ T cells in severe combined immunodeficiency (scid) mice. IV. Graft-vs.-host resistance of H-2d scid mice to intravenous injection of allogeneic H-2b (C57BL/6) spleen cells.
Claesson MH; Rudolphi A; Tscherning T; Reimann J
Eur J Immunol; 1991 Sep; 21(9):2057-62. PubMed ID: 1832384
[TBL] [Abstract][Full Text] [Related]
10. Despite efficient intrathymic negative selection of host-reactive T cells, autoimmune disease may develop in porcine thymus-grafted athymic mice: evidence for failure of regulatory mechanisms suppressing autoimmunity.
Zhao Y; Rodriguez-Barbosa JI; Shimizu A; Sachs DH; Sykes M
Transplantation; 2003 Jun; 75(11):1832-40. PubMed ID: 12811242
[TBL] [Abstract][Full Text] [Related]
11. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
Jones SC; Friedman TM; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
[TBL] [Abstract][Full Text] [Related]
12. Modulation of autoimmunity by TLR9 in the chronic graft-vs-host model of systemic lupus erythematosus.
Ma Z; Chen F; Madaio MP; Cohen PL; Eisenberg RA
J Immunol; 2006 Nov; 177(10):7444-50. PubMed ID: 17082664
[TBL] [Abstract][Full Text] [Related]
13. Protection from T helper cell-mediated graft-versus-host disease by the presence of an MHC class I alloantigen is associated with perturbation of MHC class II-restricted responses by class I-derived peptides.
Leibnitz RR; Lipsky PE; Thiele DL
J Immunol; 1995 Aug; 155(4):1784-95. PubMed ID: 7636234
[TBL] [Abstract][Full Text] [Related]
14. Expansion of intermediate T-cell receptor cells in mice with autoimmune-like graft-versus-host disease.
Ikarashi Y; Abo T; Kawai K; IIai T; Watanabe H; Suzuki K; Matsumoto Y; Omata S; Fujiwara M
Immunology; 1994 Oct; 83(2):205-12. PubMed ID: 7835936
[TBL] [Abstract][Full Text] [Related]
15. The contribution of I-Abm12 to phenotypic and functional alterations among T-cell subsets in NZB mice.
Naiki M; Yoshida SH; Watanabe Y; Izui S; Ansari AA; Gershwin ME
J Autoimmun; 1993 Apr; 6(2):131-43. PubMed ID: 8388689
[TBL] [Abstract][Full Text] [Related]
16. Chronic graft versus host disease-associated autoimmune manifestations are independently regulated by different MHC class II loci.
Bradley DS; Jennette JC; Cohen PL; Eisenberg RA
J Immunol; 1994 Feb; 152(4):1960-9. PubMed ID: 8120400
[TBL] [Abstract][Full Text] [Related]
17. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels.
Maeda T; Nomoto K
J Rheumatol; 1995 Dec; 22(12):2259-65. PubMed ID: 8835559
[TBL] [Abstract][Full Text] [Related]
18. Allosuppressor and allohelper T cells in acute and chronic graft-vs.-host disease. II. F1 recipients carrying mutations at H-2K and/or I-A.
Rolink AG; Pals ST; Gleichmann E
J Exp Med; 1983 Feb; 157(2):755-71. PubMed ID: 6218218
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the mechanism of graft-vs-host like disease in [lpr/lpr----+/+] chimera].
Matsunaga T
Hokkaido Igaku Zasshi; 1987 Sep; 62(5):779-89. PubMed ID: 2961673
[TBL] [Abstract][Full Text] [Related]
20. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
